albumin: be low in cancer patients

from Quasimodo
0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Related concepts

Parents molecule
Weight: 0.69
, protein
Weight: 0.67
, substance
Weight: 0.56
, colloid
Weight: 0.54
, agent
Weight: 0.54
Siblings hemoglobin
Weight: 0.37
, rna molecule
Weight: 0.37
, adenosine triphosphate
Weight: 0.37
, dna molecule
Weight: 0.36
, peptide
Weight: 0.36

Related properties

Property Similarity
be low in cancer patients 1.00
be low in cancer 0.93
be low in liver disease 0.83
be given to patients with ascites 0.83
be low in sepsis 0.79
be low in renal failure 0.79
be given in liver disease 0.79
decreased in multiple myeloma 0.78
be decreased in liver disease 0.77
be low in pneumonia 0.77

Priors about this statement

Cues

0.2 0.4 0.6 0.8 Joint Necessity Sufficiency Implication Entailment Contradiction Entropy

Evidence

0.2 0.4 0.6 0.8 Plausible Typical Remarkable Salient

Clauses

Remarkability exclusitivity between siblings

0.12
Rule weight: 0.13
Evidence weight: 0.91
Similarity weight: 1.00
Evidence: 0.37
¬ Remarkable(albumin, be low in cancer patients) ⋁
Evidence: 0.24
¬ Remarkable(hemoglobin, be low in cancer patients)
0.11
Rule weight: 0.13
Evidence weight: 0.95
Similarity weight: 0.83
Evidence: 0.37
¬ Remarkable(albumin, be low in cancer patients) ⋁
Evidence: 0.14
¬ Remarkable(hemoglobin, be low in liver disease)
0.10
Rule weight: 0.13
Evidence weight: 0.96
Similarity weight: 0.77
Evidence: 0.37
¬ Remarkable(albumin, be low in cancer patients) ⋁
Evidence: 0.11
¬ Remarkable(hemoglobin, be low in pneumonia)
0.09
Rule weight: 0.13
Evidence weight: 0.86
Similarity weight: 0.79
Evidence: 0.37
¬ Remarkable(albumin, be low in cancer patients) ⋁
Evidence: 0.38
¬ Remarkable(hemoglobin, be low in sepsis)

Remarkability from sibling implausibility

0.55
Rule weight: 0.60
Evidence weight: 0.91
Similarity weight: 1.00
Evidence: 0.79
Plausible(albumin, be low in cancer patients) ⋁
Evidence: 0.24
Remarkable(hemoglobin, be low in cancer patients) ⋁
Evidence: 0.55
¬ Plausible(hemoglobin, be low in cancer patients)
0.48
Rule weight: 0.60
Evidence weight: 0.95
Similarity weight: 0.83
Evidence: 0.79
Plausible(albumin, be low in cancer patients) ⋁
Evidence: 0.14
Remarkable(hemoglobin, be low in liver disease) ⋁
Evidence: 0.26
¬ Plausible(hemoglobin, be low in liver disease)
0.45
Rule weight: 0.60
Evidence weight: 0.97
Similarity weight: 0.77
Evidence: 0.79
Plausible(albumin, be low in cancer patients) ⋁
Evidence: 0.11
Remarkable(hemoglobin, be low in pneumonia) ⋁
Evidence: 0.18
¬ Plausible(hemoglobin, be low in pneumonia)
0.43
Rule weight: 0.60
Evidence weight: 0.89
Similarity weight: 0.79
Evidence: 0.79
Plausible(albumin, be low in cancer patients) ⋁
Evidence: 0.38
Remarkable(hemoglobin, be low in sepsis) ⋁
Evidence: 0.79
¬ Plausible(hemoglobin, be low in sepsis)

Salient implies Plausible

0.24
Rule weight: 0.28
Evidence weight: 0.84
Similarity weight: 1.00
Evidence: 0.79
Plausible(albumin, be low in cancer patients) ⋁
Evidence: 0.75
¬ Salient(albumin, be low in cancer patients)

Similarity expansion

0.73
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.93
Evidence: 0.91
Typical(albumin, be low in cancer patients) ⋁
Evidence: 0.86
¬ Typical(albumin, be low in cancer)
0.66
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.93
Evidence: 0.79
Plausible(albumin, be low in cancer patients) ⋁
Evidence: 0.74
¬ Plausible(albumin, be low in cancer)
0.66
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.83
Evidence: 0.91
Typical(albumin, be low in cancer patients) ⋁
Evidence: 0.82
¬ Typical(albumin, be low in liver disease)
0.65
Rule weight: 0.85
Evidence weight: 0.92
Similarity weight: 0.83
Evidence: 0.91
Typical(albumin, be low in cancer patients) ⋁
Evidence: 0.88
¬ Typical(albumin, be given to patients with ascites)
0.65
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.93
Evidence: 0.75
Salient(albumin, be low in cancer patients) ⋁
Evidence: 0.72
¬ Salient(albumin, be low in cancer)
0.63
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.79
Evidence: 0.91
Typical(albumin, be low in cancer patients) ⋁
Evidence: 0.82
¬ Typical(albumin, be low in sepsis)
0.63
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.79
Evidence: 0.91
Typical(albumin, be low in cancer patients) ⋁
Evidence: 0.83
¬ Typical(albumin, be low in renal failure)
0.62
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.79
Evidence: 0.91
Typical(albumin, be low in cancer patients) ⋁
Evidence: 0.83
¬ Typical(albumin, be given in liver disease)
0.62
Rule weight: 0.85
Evidence weight: 0.94
Similarity weight: 0.78
Evidence: 0.91
Typical(albumin, be low in cancer patients) ⋁
Evidence: 0.72
¬ Typical(albumin, decreased in multiple myeloma)
0.62
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.77
Evidence: 0.91
Typical(albumin, be low in cancer patients) ⋁
Evidence: 0.78
¬ Typical(albumin, be low in pneumonia)
0.61
Rule weight: 0.85
Evidence weight: 0.93
Similarity weight: 0.77
Evidence: 0.91
Typical(albumin, be low in cancer patients) ⋁
Evidence: 0.82
¬ Typical(albumin, be decreased in liver disease)
0.60
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.83
Evidence: 0.79
Plausible(albumin, be low in cancer patients) ⋁
Evidence: 0.72
¬ Plausible(albumin, be low in liver disease)
0.60
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.83
Evidence: 0.79
Plausible(albumin, be low in cancer patients) ⋁
Evidence: 0.74
¬ Plausible(albumin, be given to patients with ascites)
0.59
Rule weight: 0.85
Evidence weight: 0.74
Similarity weight: 0.93
Evidence: 0.37
Remarkable(albumin, be low in cancer patients) ⋁
Evidence: 0.41
¬ Remarkable(albumin, be low in cancer)
0.58
Rule weight: 0.85
Evidence weight: 0.83
Similarity weight: 0.83
Evidence: 0.75
Salient(albumin, be low in cancer patients) ⋁
Evidence: 0.69
¬ Salient(albumin, be given to patients with ascites)
0.58
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.83
Evidence: 0.75
Salient(albumin, be low in cancer patients) ⋁
Evidence: 0.74
¬ Salient(albumin, be low in liver disease)
0.57
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.77
Evidence: 0.79
Plausible(albumin, be low in cancer patients) ⋁
Evidence: 0.65
¬ Plausible(albumin, be low in pneumonia)
0.57
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.79
Evidence: 0.79
Plausible(albumin, be low in cancer patients) ⋁
Evidence: 0.74
¬ Plausible(albumin, be low in renal failure)
0.57
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.79
Evidence: 0.79
Plausible(albumin, be low in cancer patients) ⋁
Evidence: 0.76
¬ Plausible(albumin, be low in sepsis)
0.57
Rule weight: 0.85
Evidence weight: 0.86
Similarity weight: 0.78
Evidence: 0.79
Plausible(albumin, be low in cancer patients) ⋁
Evidence: 0.67
¬ Plausible(albumin, decreased in multiple myeloma)
0.56
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.79
Evidence: 0.79
Plausible(albumin, be low in cancer patients) ⋁
Evidence: 0.76
¬ Plausible(albumin, be given in liver disease)
0.56
Rule weight: 0.85
Evidence weight: 0.85
Similarity weight: 0.77
Evidence: 0.79
Plausible(albumin, be low in cancer patients) ⋁
Evidence: 0.72
¬ Plausible(albumin, be decreased in liver disease)
0.56
Rule weight: 0.85
Evidence weight: 0.84
Similarity weight: 0.77
Evidence: 0.75
Salient(albumin, be low in cancer patients) ⋁
Evidence: 0.62
¬ Salient(albumin, be low in pneumonia)
0.55
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.79
Evidence: 0.75
Salient(albumin, be low in cancer patients) ⋁
Evidence: 0.75
¬ Salient(albumin, be low in renal failure)
0.55
Rule weight: 0.85
Evidence weight: 0.77
Similarity weight: 0.83
Evidence: 0.37
Remarkable(albumin, be low in cancer patients) ⋁
Evidence: 0.36
¬ Remarkable(albumin, be given to patients with ascites)
0.54
Rule weight: 0.85
Evidence weight: 0.82
Similarity weight: 0.78
Evidence: 0.75
Salient(albumin, be low in cancer patients) ⋁
Evidence: 0.71
¬ Salient(albumin, decreased in multiple myeloma)
0.54
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.79
Evidence: 0.75
Salient(albumin, be low in cancer patients) ⋁
Evidence: 0.80
¬ Salient(albumin, be low in sepsis)
0.54
Rule weight: 0.85
Evidence weight: 0.81
Similarity weight: 0.77
Evidence: 0.75
Salient(albumin, be low in cancer patients) ⋁
Evidence: 0.74
¬ Salient(albumin, be decreased in liver disease)
0.53
Rule weight: 0.85
Evidence weight: 0.80
Similarity weight: 0.79
Evidence: 0.75
Salient(albumin, be low in cancer patients) ⋁
Evidence: 0.80
¬ Salient(albumin, be given in liver disease)
0.50
Rule weight: 0.85
Evidence weight: 0.70
Similarity weight: 0.83
Evidence: 0.37
Remarkable(albumin, be low in cancer patients) ⋁
Evidence: 0.47
¬ Remarkable(albumin, be low in liver disease)
0.50
Rule weight: 0.85
Evidence weight: 0.75
Similarity weight: 0.77
Evidence: 0.37
Remarkable(albumin, be low in cancer patients) ⋁
Evidence: 0.40
¬ Remarkable(albumin, be low in pneumonia)
0.47
Rule weight: 0.85
Evidence weight: 0.70
Similarity weight: 0.79
Evidence: 0.37
Remarkable(albumin, be low in cancer patients) ⋁
Evidence: 0.47
¬ Remarkable(albumin, be low in renal failure)
0.46
Rule weight: 0.85
Evidence weight: 0.70
Similarity weight: 0.77
Evidence: 0.37
Remarkable(albumin, be low in cancer patients) ⋁
Evidence: 0.48
¬ Remarkable(albumin, be decreased in liver disease)
0.44
Rule weight: 0.85
Evidence weight: 0.66
Similarity weight: 0.79
Evidence: 0.37
Remarkable(albumin, be low in cancer patients) ⋁
Evidence: 0.54
¬ Remarkable(albumin, be given in liver disease)
0.44
Rule weight: 0.85
Evidence weight: 0.65
Similarity weight: 0.79
Evidence: 0.37
Remarkable(albumin, be low in cancer patients) ⋁
Evidence: 0.55
¬ Remarkable(albumin, be low in sepsis)
0.43
Rule weight: 0.85
Evidence weight: 0.65
Similarity weight: 0.78
Evidence: 0.37
Remarkable(albumin, be low in cancer patients) ⋁
Evidence: 0.55
¬ Remarkable(albumin, decreased in multiple myeloma)

Typical and Remarkable implies Salient

0.13
Rule weight: 0.14
Evidence weight: 0.92
Similarity weight: 1.00
Evidence: 0.75
Salient(albumin, be low in cancer patients) ⋁
Evidence: 0.91
¬ Typical(albumin, be low in cancer patients) ⋁
Evidence: 0.37
¬ Remarkable(albumin, be low in cancer patients)

Typical implies Plausible

0.39
Rule weight: 0.48
Evidence weight: 0.80
Similarity weight: 1.00
Evidence: 0.79
Plausible(albumin, be low in cancer patients) ⋁
Evidence: 0.91
¬ Typical(albumin, be low in cancer patients)

Typicality and Rermarkability incompatibility between siblings

0.10
Rule weight: 0.14
Evidence weight: 0.71
Similarity weight: 1.00
Evidence: 0.37
¬ Remarkable(albumin, be low in cancer patients) ⋁
Evidence: 0.79
¬ Typical(hemoglobin, be low in cancer patients)
0.09
Rule weight: 0.14
Evidence weight: 0.79
Similarity weight: 0.83
Evidence: 0.37
¬ Remarkable(albumin, be low in cancer patients) ⋁
Evidence: 0.57
¬ Typical(hemoglobin, be low in liver disease)
0.09
Rule weight: 0.14
Evidence weight: 0.82
Similarity weight: 0.77
Evidence: 0.37
¬ Remarkable(albumin, be low in cancer patients) ⋁
Evidence: 0.49
¬ Typical(hemoglobin, be low in pneumonia)
0.07
Rule weight: 0.14
Evidence weight: 0.66
Similarity weight: 0.79
Evidence: 0.37
¬ Remarkable(albumin, be low in cancer patients) ⋁
Evidence: 0.91
¬ Typical(hemoglobin, be low in sepsis)